Literature DB >> 6866715

Formulation of a stable vidarabine infusion fluid.

L M Stolk, W Huisman, H D Nordemann, A Vyth.   

Abstract

Decomposition of vidarabine in a 5% glucose infusion fluid after steam sterilization was measured by HPLC and TLC analysis. After sterilization for 60 minutes at 100 degrees C and 20 minutes at 120 degrees C no degradation could be observed. A slight but significant degradation was observed after sterilization for 60 minutes at 120 degrees C followed by storage for eight months. Assuming 5% loss of content to be acceptable, it was concluded that a vidarabine infusion fluid can be sterilized for 20 minutes at 120 degrees C and stored at room temperature for at least eight months afterwards.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866715     DOI: 10.1007/bf01960076

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  7 in total

1.  Selective analysis for adenosine using reversed-phase high-pressure liquid chromatography.

Authors:  R A Hartwick; P R Brown
Journal:  J Chromatogr       Date:  1977-07-01

2.  Stability-indicating assay for vidarabine.

Authors:  W H Hong; D H Szulczewski
Journal:  J Pharm Sci       Date:  1979-04       Impact factor: 3.534

3.  [Identification and quantitative determination of adenosine in pharmaceutic preparations by thin-layer chromatography].

Authors:  F Pechtold; H Rentsch
Journal:  Arzneimittelforschung       Date:  1967-01

4.  Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate.

Authors:  J K Preiksaitis; B Lank; P K Ng; L Brox; G A LePage; D L Tyrrell
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

5.  Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.

Authors:  R J Whitley; B C Tucker; A W Kinkel; N H Barton; R F Pass; J D Whelchel; C G Cobbs; A G Diethelm; R A Buchanan
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  Effect of vidarabine on chronic hepatitis B virus infection.

Authors:  R B Pollard; J L Smith; A Neal; P B Gregory; T C Merigan; W S Robinson
Journal:  JAMA       Date:  1978-04-21       Impact factor: 56.272

7.  9-beta-D-arabinofuranosyladenine 5'-phosphate metabolism and excretion in humans.

Authors:  G A LePage; S R Naik; S B Katakkar; A Khaliq
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

  7 in total
  2 in total

1.  Formulation of a stable vidarabine phosphate injection.

Authors:  M S Kwee; L M Stolk
Journal:  Pharm Weekbl Sci       Date:  1984-06-22

2.  Design and synthesis of vidarabine prodrugs as antiviral agents.

Authors:  Wei Shen; Jae-Seung Kim; Phillip E Kish; Jie Zhang; Stefanie Mitchell; Brian G Gentry; Julie M Breitenbach; John C Drach; John Hilfinger
Journal:  Bioorg Med Chem Lett       Date:  2008-12-10       Impact factor: 2.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.